Calithera Biosciences Valuation
Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Calithera Biosciences prevailing Real Value cannot be determined due to lack of data. The current price of Calithera Biosciences is $0.0. Our model approximates the value of Calithera Biosciences from analyzing the firm fundamentals such as Current Valuation of (1.1 M), shares owned by insiders of 1.07 %, and Return On Equity of -1.14 as well as examining its technical indicators and probability of bankruptcy.
Calithera Biosciences Total Value Analysis
Calithera Biosciences is currently expected to have valuation of (1.1 M) with market capitalization of 341.07 K, debt of 1.67 M, and cash on hands of 41.79 M. The negative valuation of Calithera Biosciences may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the Calithera Biosciences fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(1.1 M) | 341.07 K | 1.67 M | 41.79 M |
Calithera Biosciences Asset Utilization
One of the ways to look at asset utilization of Calithera is to check how much profit was generated for every dollar of assets it reports. Calithera Biosciences shows a negative utilization of assets of -0.56 percent, losing $0.005629 for each dollar of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Calithera Biosciences shows how discouraging it operates for each dollar spent on its assets.Calithera Biosciences Ownership Allocation
Almost 72.17 percent of Calithera Biosciences outstanding shares are held by general public with 1.07 (percent) owned by insiders and only 26.76 % by other corporate entities.Calithera Biosciences Profitability Analysis
Net Loss for the year was (39.65 M) with loss before overhead, payroll, taxes, and interest of (42.7 M).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Calithera Biosciences' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Calithera Biosciences and how it compares across the competition.
Calithera Biosciences Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 5 M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Consideration for investing in Calithera Pink Sheet
If you are still planning to invest in Calithera Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Calithera Biosciences' history and understand the potential risks before investing.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |